Re: Akt phosphorylation and gefitinib efficacy in patients with advanced non-small-cell lung cancer

被引：1
|
作者：
Tsurutani, J [1 ]
Dennis, PA [1 ]
机构：
[1] NCI, Canc Therapeut Branch, NIH, Bethesda, MD 20889 USA
来源：
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2004年 / 96卷 / 23期
关键词：
D O I：
10.1093/jnci/djh342
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1795 / 1795
页数：1
相关论文
共 50 条
  • [1] Re: Akt phosphorylation and gefitinib efficacy in patients with advanced non-small-cell lung cancer - Response
    Cappuzzo, F
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (23) : 1795 - 1796
  • [2] Akt phosphorylation and gefitinib efficacy in patients with advanced non-small-cell lung cancer
    Cappuzzo, F
    Magrini, E
    Ceresoli, GL
    Bartolini, S
    Rossi, E
    Ludovini, V
    Gregorc, V
    Ligorio, C
    Cancellieri, A
    Damiani, S
    Spreafico, A
    Paties, CT
    Lombardo, L
    Calandri, C
    Bellezza, G
    Tonato, M
    Crinò, L
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (15) : 1133 - 1141
  • [3] Akt phosphorylation and gefitinib efficacy in patients with advanced non-small-cell lung cancer
    De Braud, F
    De Pas, T
    Spaggiari, L
    Veronesi, G
    Curigliano, G
    Noberasco, C
    Pelosi, G
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (06) : 461 - 462
  • [4] Akt phosphorylation and gefitinib efficacy in patients with advanced non-small-cell lung cancer - Reply
    Cappuzzo, F
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (06) : 462 - 463
  • [5] Clinical predictive factors, AKT phosphorylation, EGFR mutations and gefitinib activity in patients with advanced non-small-cell lung cancer
    Kang, J
    Kim, J
    Shin, J
    Im, S
    Lee, Y
    Lee, M
    Woo, I
    Lee, K
    Kim, S
    Kim, Y
    [J]. LUNG CANCER, 2005, 49 : S109 - S109
  • [6] Gefitinib for Chinese patients with advanced non-small-cell lung cancer
    Xiaotong, Z
    Longyun, L
    Xinlin, MU
    [J]. LUNG CANCER, 2004, 45 : S79 - S79
  • [7] Gefitinib in the treatment of advanced non-small-cell lung cancer
    Reck, Martin
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (04) : 401 - 412
  • [8] Gefitinib for refractory advanced non-small-cell lung cancer
    Moriguchi, H
    Kim, TY
    Sato, C
    [J]. LANCET, 2006, 367 (9507): : 299 - 300
  • [9] Gefitinib therapy for advanced non-small-cell lung cancer
    Liu, CY
    Seen, S
    [J]. ANNALS OF PHARMACOTHERAPY, 2003, 37 (11) : 1644 - 1653
  • [10] Gefitinib or docetaxel in advanced non-small-cell lung cancer
    Cullen, Michael
    Thatcher, Nicholas
    [J]. LANCET, 2008, 372 (9652): : 1785 - 1786
12345